VIGL Vigil Neuro: Multiplikator forward rega marang pendapatan
Vigil Neuroscience is optimizing biomaterial supplies and developing neuroimmunological alliances to create protective brain therapies. The forward P/S metric visualizes the effectiveness of this strategy, where indicates the current valuation level. High R&D expenditures and patent protection for microglial drugs create a significant barrier for competitors, ensuring the asset's long-term sustainability.
Rincian analitis perusahaan Vigil Neuroscience
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Vigil Neuroscience|VIGL - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Vigil Neuroscience, Inc.|VIGL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Vigil Neuroscience, Inc.|VIGL - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Vigil Neuroscience|Likuiditas cepet vigilneuro.com
- data bathi bisnis lan rasio investasi:
VIGL - Bathi perusahaan|Proyeksi bathi mangsa ngarep Vigil Neuroscience|VIGL - Koefisien rega marang bathi|Pangali Forward P/E Vigil Neuroscience, Inc.|VIGL - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vigil Neuroscience, Inc.|VIGL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Vigil Neuroscience|VIGL - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan vigilneuro.com|VIGL - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vigil Neuroscience
- statistik dodolan lan pendapatan perusahaan:
Analisis kabeh metrik perusahaan:Vigil Neuro VIGL
This indicator compares the current market value of Vigil Neuroscience (VIGL) with projected sales volumes, allowing for an assessment of the premium paid for future cash flows. By analyzing the forward price-to-sales ratio, an investor can see how the resilience of drug substance supply chains reduces operational risks, which directly impacts the company's fundamental value and its investment attractiveness on the chart.
Analisis perusahaan pesaing
Multiplikator Forward P/S BIIB (Biogen)|Neurocrine (NBIX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|RGC: Multiplikator forward rega marang pendapatan|AXSM - Multiplikator Forward P/S|ACADIA Pharmaceuticals (ACAD) - Rasio rega marang prakiraan pendapatan|xenon-pharma.com - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Therapeutics, Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Supernus Pharmaceuticals, Inc. SUPN|Rasio rega marang prakiraan pendapatan Catalyst Pharmaceuticals Inc (CPRX)|Rasio kapitalisasi marang dodolan sing dikarepake Denali Corp|Multiplikator Forward P/S HRMY (Harmony Biosciences)|BHVN - Multiplikator forward rega marang pendapatan|Amylyx Pharmaceuticals, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Trevi Therapeutics Inc TRVI|PRAX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Anavex Life Sciences Corp (AVXL)|Rasio rega marang prakiraan pendapatan CeriBell, Inc.|Kapitalisasi marang prakiraan pendapatan PRTA (Prothena Corporation)|Multiplikator Forward P/S ALEC|Multiplikator forward rega marang pendapatan Annexon Biosciences ANNX|Multiplikator Forward P/S OMER (Omeros)|Neurogene Therapeutics (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ACIU: Multiplikator forward rega marang pendapatan|VYGR: Rasio rega marang prakiraan pendapatan|NMRA: Multiplikator Forward P/S|SCLX - Rasio kapitalisasi marang dodolan sing dikarepake|TVGN (Tevogen Bio Holdings, Inc.) - Multiplikator Forward P/S|ACOG - Prakiraan rega marang pendapatan|Rasio rega marang prakiraan pendapatan Cognition Therapeutics (CGTX)|Rasio rega marang prakiraan pendapatan IKT (inhibikase.com)|Rasio rega marang prakiraan pendapatan Cassava Sciences SAVA|ASRT: Kapitalisasi marang prakiraan pendapatan|Coya - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Vistagen Therapeutics|OVID (ovidrx.com) - Multiplikator forward rega marang pendapatan|acumenpharm.com (ABOS) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan CervoMed|ATHE: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Clene Inc. (CLNN)|PEPG - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Jupiter Neurosciences Inc - Multiplikator forward rega marang pendapatan|relmada.com - Rasio rega marang prakiraan pendapatan|Annovis Bio - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Grace Therapeutics, Inc. GRCE|AIFF: Multiplikator Forward P/S|Prakiraan rega marang pendapatan Klotho Neurosciences KLTO|NRSN (NeuroSense Therapeutics Ltd) - Multiplikator Forward P/S|revivapharma.com (RVPH) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan MetaVia Inc (MTVA)|Rasio rega marang prakiraan pendapatan NRXS (NeurAxis Inc.)|Helius Medical Technologies - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PASG|NEUP - Rasio rega marang prakiraan pendapatan|NERV (minervaneurosciences.com) - Kapitalisasi marang prakiraan pendapatan|ATHA: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Addex Therapeutics Ltd. (ADXN)|Multiplikator forward rega marang pendapatan ALZN|Multiplikator Forward P/S Cyclerion|Rasio rega marang prakiraan pendapatan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Cortigent CRGT|Avenue Therapeutics Inc. (ATXI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BCLI - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Cara Therapeutics Inc CARA|CHRO: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Eliem Therapeutics Inc.|ITCI (Intra-Cellular Therapies Inc.) - Multiplikator Forward P/S|Longboard Pharmaceuticals Inc (LBPH) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S MRNS|NKGN - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan NeuroBo Pharmaceuticals NRBO|SAGE: Kapitalisasi marang prakiraan pendapatan|Synaptogenix - Multiplikator Forward P/S|Trevena Inc. (TRVN) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cerevel Corp (CERE)
